Since we demonstrated that high doses of ascorbic acid (ASC) preferentially kill leukemic blasts from APL patients while sparing normal HSCs [17,18] we aimed to define the effect of PML/RARa on NRF2 function in hematopoietic cells. The gene discussed is PML; the disease is acute promyelocytic leukemia.